Cite

HARVARD Citation

    Rochau, U. et al. (n.d.). Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia. Leukemia & lymphoma. 56 (8), pp. 2315-2325. [Online]. 
  
Back to record